Provided by Tiger Trade Technology Pte. Ltd.

Entrada Therapeutics, Inc.

6.82
-0.2900-4.08%
Volume:29.89K
Turnover:204.03K
Market Cap:264.76M
PE:-1.72
High:7.18
Open:7.00
Low:6.73
Close:7.11
52wk High:16.45
52wk Low:5.02
Shares:38.82M
Float Shares:22.72M
Volume Ratio:0.77
T/O Rate:0.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9676
EPS(LYR):-3.4746
ROE:-54.09%
ROA:-29.20%
PB:1.13
PE(LYR):-1.96

Loading ...

Entrada Therapeutics Announces Recipients of Fourth Annual DREAMS Grant Program

GlobeNewswire
·
3 hours ago

MPM BioVentures 2014 Reports Entrada Therapeutics Share Disposal Worth $1.89 Million

Reuters
·
14 hours ago

MPM BioVentures 2014 Reports Entrada Therapeutics Common Stock Sale Worth $621,585.04

Reuters
·
Sep 04

Analysts Conflicted on These Healthcare Names: Definitive Healthcare Corp (DH) and Entrada Therapeutics Inc (TRDA)

TIPRANKS
·
Sep 03

Entrada Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Reuters
·
Sep 03

MPM BioVentures 2014 Reports $612,948 Entrada Therapeutics Common Share Sale

Reuters
·
Sep 01

MPM BioVentures 2018 Reports Entrada Therapeutics Common Stock Disposal Worth $471,391.64

Reuters
·
Aug 27

Major Insider Moves Shake Up Entrada Therapeutics Inc. Stock

TIPRANKS
·
Aug 11

5AM Ventures V Reports Entrada Therapeutics Share Disposal Worth $431,620

Reuters
·
Aug 11

Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), Janux Therapeutics Inc (JANX) and Entrada Therapeutics Inc (TRDA)

TIPRANKS
·
Aug 10

NextCure Q2 Net Loss Narrows on Lower Expenses

Reuters
·
Aug 07

PepGen Q2 Net Loss Narrows as Expenses Fall

Reuters
·
Aug 06

Biomea Fusion Q2 Loss Narrows, Cash Runway into Q2 2027

Reuters
·
Aug 06

Tenaya Therapeutics Q2 Net Loss Widens on Impairment Charge

Reuters
·
Aug 06

Editas Medicine Q2 Net Loss Narrows and Beats Estimates

Reuters
·
Aug 06

Black Diamond Therapeutics Q2 Net Loss Narrows Year over Year

Reuters
·
Aug 06

Entrada Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Entrada Therapeutics Publishes Corporate Presentation on Genetic Medicines Pipeline for Neuromuscular and Inherited Retinal Diseases

Reuters
·
Aug 05

Entrada Therapeutics Q2 EPS $(1.01) Beats $(1.09) Estimate, Sales $898.000K Beat $411.429K Estimate

Benzinga Earnings
·
Aug 05

Entrada Therapeutics Q2 Net Loss Narrows on Lower Costs

Reuters
·
Aug 05